Marek Wagner
Impact in
- Immunology top 10%
- Immune Cell Function and Interaction
- IL-33, ST2, and ILC Pathways
- Immune cells in cancer
- Oncology top 10%
- Lymphatic System and Diseases
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 15
- IL-33, ST2, and ILC Pathways 10
- Immune Cell Function and Interaction 9
- Immune cells in cancer 5
- Oncology 11
- Lymphatic System and Diseases 6
- Cancer Cells and Metastasis 4
- Co-authors
- Helge Wiig (11 shared papers)Shigeo Koyasu (9 shared papers)Andrew C. Dudley (3 shared papers)Rolf Bjerkvig (5 shared papers)Hans Petter Eikesdal (3 shared papers)Kari Alitalo (2 shared papers)Kazuyo Moro (2 shared papers)Maria A.S. Broggi (1 shared paper)
- Journals
- Frontiers in Immunology (3 papers)Adipocyte (2 papers)Expert Opinion on Therapeutic Targets (2 papers)Trends in cancer (2 papers)Arteriosclerosis Thrombosis and Vascular Biology (2 papers)
- Partner nations
- NorwayJapanUnited States
In The Last Decade
Marek Wagner
27 papers receiving 722 citations
Peers
Comparison fields: 5 of 76
- Immunology 289
- Oncology 306
- Cancer Research 85
- Physiology 96
- Molecular Biology 241
Countries citing papers authored by Marek Wagner
This map shows the geographic impact of Marek Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Wagner more than expected).
Fields of papers citing papers by Marek Wagner
This network shows the impact of papers produced by Marek Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Wagner. The network helps show where Marek Wagner may publish in the future.
Co-authors
The 25 scholars most cited alongside Marek Wagner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 152 | |
| 2 | 2015 | 77 | |
| 3 | 2012 | 62 | |
| 4 | 2020 | 50 | |
| 5 | 2015 | 45 | |
| 6 | 2019 | 36 | |
| 7 | 2014 | 35 | |
| 8 | 2009 | 32 | |
| 9 | 2019 | 27 | |
| 10 | 2017 | 25 | |
| 11 | 2013 | 24 | |
| 12 | 2013 | 22 | |
| 13 | 2013 | 22 | |
| 14 | 2016 | 20 | |
| 15 | 2012 | 19 | |
| 16 | A dangerous duo in adipose tissue: high-mobility group box 1 protein and macrophages. | 2014 | 15 |
| 17 | 2017 | 14 | |
| 18 | 2021 | 11 | |
| 19 | 2019 | 7 | |
| 20 | 2021 | 5 |
About Marek Wagner
Marek Wagner is a scholar working on Immunology, Oncology, Surgery, Molecular Biology and Epidemiology, having authored 30 papers that have together received 725 indexed citations. Recurring topics across this work include IL-33, ST2, and ILC Pathways (10 papers), Immune Cell Function and Interaction (9 papers), Lymphatic System and Diseases (6 papers), Eosinophilic Esophagitis (5 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers), Immune cells in cancer (5 papers), Cancer Cells and Metastasis (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). The work is most often cited by research in Immunology (289 citations), Oncology (306 citations), Cancer Research (85 citations), Physiology (96 citations) and Molecular Biology (241 citations). Marek Wagner has collaborated with scholars based in Norway, Japan and United States. Frequent co-authors include Helge Wiig, Shigeo Koyasu, Andrew C. Dudley, Rolf Bjerkvig, Hans Petter Eikesdal, Kari Alitalo, Kazuyo Moro, Maria A.S. Broggi, Thomas F. Gajewski and Melody A. Swartz. Their work appears in journals such as Frontiers in Immunology, Adipocyte, Expert Opinion on Therapeutic Targets, Trends in cancer and Arteriosclerosis Thrombosis and Vascular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.